Evidence map›Paper›PMID 41975236›Full record

ArticleThoracic cancer2026

Study on the Modes of Cell Death in Lung Cancer Epithelial Cells During Acute EBV Infection Using a Co-Culture Model.

Xinyue Zhang, Chenpeng Li, Shuilian Zhang, Wenqing Yan, Yu Chen, Danxia Lu, Zhi Xie, Pai Zhang, Xue Pan

Abstract read
In one paragraph

Article in Thoracic cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xinyue ZhangThe First School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, China.
Chenpeng LiMedical Research Institute, Guangdong Geriatric Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
Shuilian ZhangMedical Research Institute, Guangdong Geriatric Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
Wenqing YanMedical Research Institute, Guangdong Geriatric Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
Yu ChenMedical Research Institute, Guangdong Geriatric Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
Danxia LuMedical Research Institute, Guangdong Geriatric Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
Zhi XieMedical Research Institute, Guangdong Geriatric Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
Pai ZhangMedical Research Institute, Guangdong Geriatric Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
Xue PanMedical Research Institute, Guangdong Geriatric Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.ORCID https://orcid.org/0000-0002-8699-1962

Funding

Guangdong Provincial People's Hospital Research Grant No. 8220101011
6 · The paper itself

Abstract

objectivePulmonary lymphoepithelial carcinoma is an EBV-associated malignancy; however, the pathogenesis of virus-associated cancers remains incompletely elucidated. In particular, the early pathological changes and fate decisions of pulmonary epithelial cells following acute EBV infection have yet to be fully elucidated. This study aimed to investigate cell death modes of lung epithelial cells upon acute EBV infection.

methodsAn acute infection model was established by co-culturing EBV-positive Akata cells with lung cancer cells. Following infection, we evaluated morphological alterations and modes of cell death using immunofluorescence staining and confocal laser scanning microscopy.

resultsThe co-culture system successfully established a 72-h acute EBV infection in lung cancer cells, with ~10.3% of epithelial cells exhibiting EBV-associated GFP fluorescence. Under these conditions, the majority of epithelial cells underwent cell death. More than half of the epithelial cells died by day 5 of co-culture, and mortality progressively increased. At 72 h post-infection, immunofluorescence analysis of pMLKL, cGSDMD, and cCASP3 revealed a significant upregulation of pMLKL protein expression (p < 0.001), whereas no significant differences were observed in cGSDMD (p > 0.05) or cCASP3 (p > 0.05) levels. ~15.1% of the remaining epithelial cells following B-cell removal exhibited "cell-in-cell" structures. The internalized B cells underwent various forms of death, including apoptosis, pyroptosis, and necroptosis.

conclusionAcute EBV infection drives lung cancer epithelial cell death through pMLKL-mediated necroptosis, without significant involvement of apoptosis or pyroptosis. Internalized B cells within "cell-in-cell" structures exhibit multiple death modalities. These findings provided novel insights into cellular fate decisions in EBV-infected epithelium prior to latency.

Indexed as

Epithelial CellsEpstein-Barr Virus InfectionsHerpesvirus 4, HumanLung NeoplasmsCell DeathCell Line, TumorCoculture TechniquesHumansapoptosisEBVnecroptosisprimary pulmonary lymphoepithelial carcinomapyroptosis

Identifiers

PMID41975236
PMCPMC13076187

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.